Clinical Trial Update: Trial of Abiraterone Acetate Plus LHRH-therapy Versus Abiraterone Acetate Sparing LHRH-therapy in Patients With Progressive Chemotherapy-naïve Castration-resistant Prostate Cancer (SPARE) [Phase 2]

View source ↗

Summary

Phase 2 trial SPARE comparing abiraterone acetate plus LHRH therapy versus abiraterone acetate with sparing LHRH therapy in chemotherapy-naïve progressive castr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Abiraterone acetate (Abiraterone acetate)
• LHRH (leuprolin or luteinizing hormone-releasing hormone analogue)

Snippet

Sponsor: Universität des Saarlandes | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED